Methotrexate (Metoject® prefilled pen)

DRUG2 trials

Sponsors

medac GmbH, Chinese University of Hong Kong

Conditions

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)

Phase 1

Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient

CompletedNCT01871961

medac GmbHRheumatoid Arthritis (RA)

Start: 2012-10-31End: 2013-05-31Updated: 2015-03-17

Phase 4

Preventing Structural Damage in Early Psoriatic Arthritis

RecruitingNCT07486843

Chinese University of Hong KongPsoriatic Arthritis (PsA)

Start: 2026-03-16End: 2028-12-31Target: 108Updated: 2026-03-23